Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Pearson

Showing results (471-480 of 632) with videos related to

Pageof 64
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2016
Targeting MDM2 for Treatment of Adenoid Cystic CarcinomaKristy A Warner, Felipe Nör, Gerson A Acasigua, et al.
Frontiers in Oncology|August 2, 2021
Doublecortin-Like Kinase 1 (DCLK1) Is a Novel NOTCH Pathway Signaling Regulator in Head and Neck Squamous Cell CarcinomaEsther C Broner, Jonathan A Trujillo, Michael Korzinkin, et al.
Scientific Reports|July 1, 2026
Retraction Note: Dysregulation of ghrelin in diabetes impairs the vascular reparative response to hindlimb ischemia in a mouse model; clinical relevance to peripheral artery diseaseJoshua P H Neale, James T Pearson, Kate N Thomas, et al.
Scientific Reports|December 24, 2017
Widespread Coronary Dysfunction in the Absence of HDL Receptor SR-B1 in an Ischemic Cardiomyopathy Mouse ModelJames T Pearson, Misa Yoshimoto, Yi Ching Chen, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|April 10, 2023
Clinicians' perception of oral potentially malignant disorders: a pitfall for image annotation in supervised learningAnna Luíza Damaceno Araújo, Eduardo Santos Carlos de Souza, Isabel Schausltz Pereira Faustino, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2020
4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasisDarren S Bryan, Melinda Stack, Katarzyna Krysztofiak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2019
Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell-recruiting Antibody Optimized for Cytotoxicity and Cytokine ReleaseChristina L Zuch de Zafra, Flordeliza Fajardo, Wendy Zhong, et al.
JAMA Oncology|March 6, 2025
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical TrialAri J Rosenberg, Aditya Juloori, Michael J Jelinek, et al.
Clinical Science (London, England : 1979)|January 22, 2021
β-blockade prevents coronary macro- and microvascular dysfunction induced by a high salt diet and insulin resistance in the Goto-Kakizaki ratJames T Pearson, Hamish P Thambyah, Mark T Waddingham, et al.
Nature Communications|March 20, 2026
MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trialAlexander T Pearson, Jameel Muzaffar, Kedar Kirtane, et al.
Pageof 64

Showing results (471-480 of 632) with videos related to

Sort By:
Pageof 64
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2016
Targeting MDM2 for Treatment of Adenoid Cystic CarcinomaKristy A Warner, Felipe Nör, Gerson A Acasigua, et al.
Frontiers in Oncology|August 2, 2021
Doublecortin-Like Kinase 1 (DCLK1) Is a Novel NOTCH Pathway Signaling Regulator in Head and Neck Squamous Cell CarcinomaEsther C Broner, Jonathan A Trujillo, Michael Korzinkin, et al.
Scientific Reports|July 1, 2026
Retraction Note: Dysregulation of ghrelin in diabetes impairs the vascular reparative response to hindlimb ischemia in a mouse model; clinical relevance to peripheral artery diseaseJoshua P H Neale, James T Pearson, Kate N Thomas, et al.
Scientific Reports|December 24, 2017
Widespread Coronary Dysfunction in the Absence of HDL Receptor SR-B1 in an Ischemic Cardiomyopathy Mouse ModelJames T Pearson, Misa Yoshimoto, Yi Ching Chen, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|April 10, 2023
Clinicians' perception of oral potentially malignant disorders: a pitfall for image annotation in supervised learningAnna Luíza Damaceno Araújo, Eduardo Santos Carlos de Souza, Isabel Schausltz Pereira Faustino, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2020
4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasisDarren S Bryan, Melinda Stack, Katarzyna Krysztofiak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2019
Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell-recruiting Antibody Optimized for Cytotoxicity and Cytokine ReleaseChristina L Zuch de Zafra, Flordeliza Fajardo, Wendy Zhong, et al.
JAMA Oncology|March 6, 2025
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical TrialAri J Rosenberg, Aditya Juloori, Michael J Jelinek, et al.
Clinical Science (London, England : 1979)|January 22, 2021
β-blockade prevents coronary macro- and microvascular dysfunction induced by a high salt diet and insulin resistance in the Goto-Kakizaki ratJames T Pearson, Hamish P Thambyah, Mark T Waddingham, et al.
Nature Communications|March 20, 2026
MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trialAlexander T Pearson, Jameel Muzaffar, Kedar Kirtane, et al.
Pageof 64